Tumor hypoxia has been reported to cause a functional loss in DNA mismatch repair (MMR) system as a result of downregulation of MMR genes, although the precise molecular mechanisms remain unclear. In this study, we focused on the downregulation of a key MMR gene, MLH1, and demonstrated that hypoxia-inducible transcription repressors, differentiated embryo chondrocytes (DEC1 and 2), participated in its transcriptional regulation via their bindings to E-box-like motif(s) in MLH1 promoter region. In all cancer cell lines examined, hypoxia increased expression of DEC1 and 2, known as hypoxia-inducible genes, but decreased MLH1 expression in an exposure time-dependent manner at both the mRNA and protein levels. Co-transfection reporter assay revealed that DEC1 and, to greater extent, DEC2 as well as hypoxia-repressed MLH1 promoter activity. We further found that the action was remarkably inhibited by trichostatin A, and identified a possible DEC-response element in the MLH1 promoter. In vitro electrophoretic gel mobility shift and chromatin immunoprecipitation assays demonstrated that DEC1 or 2 directly bounds to the suggested element, and transient transfection assay revealed that overexpression of DEC2 repressed endogenous MLH1 expression in the cells. Hypoxia-induced DEC may impair MMR function through repression of MLH1 expression, possibly via the histone deacethylasemediated mechanism in cancer cells.
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Introduction
Hypoxia is a common feature in many solid tumors and the microenvironment is now recognized as a key factor linked to the biologically aggressive phenotypes and their resistance to chemotherapeutic agents and irradiation therapies (Teicher, 1994; Brown and Giaccia, 1998; Cairns et al., 2006) . Extensive studies of molecular mechanisms have shown that transcription factor hypoxia-inducible factor-1a (HIF-1a) is a key regulator of hypoxic reaction; these studies have led to a better understanding of the mechanisms of HIF-1a activation and the subsequent alteration of gene expressions under hypoxic conditions (Harris, 2002; Denko et al., 2003; Semenza, 2003; Poellinger and Johnson, 2004) .
Recently, revealing findings have reported that hypoxia can reduce expression of several DNA repair genes-MLH1, RAD51, BRCA1 and MSH2-resulting in genomic instability in several cancer cell lines (Mihaylova et al., 2003; Bindra et al., 2004 Bindra et al., , 2005 Koshiji et al., 2005; Glazer, 2006, 2007) . Since the human mismatch repair (MMR) system plays a critical role in the maintenance of genomic integrity, the mechanisms of transcriptional repression, especially in MLH1 and MSH2 genes, are of key importance in tumor biology: germ line mutations in MLH1 (B50%) and MSH2 (B40%) exist in approximately half of all hereditary non-polyposis colorectal cancer patients (Hoeijmakers, 2001; Peltoma¨ki, 2001) . Under hypoxic conditions, the cellular DNA repair function becomes impaired, which causes hypermutability to DNA damage (Reynolds et al., 1996; Yuan et al., 2000) . These findings strongly suggest that tumor hypoxia probably causes loss of genomic stability through suppression of MMR functions, and that defects of MMR function may dramatically increase mutation rates.
These studies have also suggested that a transcription factor, E2Fs, p130, HIF-1a, SP-1 or Myc/Max system may participate in the mechanisms of downregulation of BRCA1, RAD51, MSH2 or MLH1, but details remain unclear. Among numerous hypoxia-inducible genes, differentiated embryo chondrocyte (DEC) 1 and 2 may be the most likely candidates (Ivanova et al., 2001; Miyazaki et al., 2002) . DEC1 and 2 have been reported to participate in the transcriptional repression of PPARG, PER, STAT1 and themselves via E-box or other motifs in their promoter regions, which results in the regulation of adipogenesis, circadian rhythm, immune system or carcinogenesis (Honma et al., 2002; Yun et al., 2002; Ivanova et al., 2007) . DEC1 (also known as BHLHB2/STRA13) was originally identified as the gene expressed in cyclic AMP-dependently differentiated embryo chondrocytes that encode a basic helix-loop-helix (bHLH) transcription factor (Shen et al., 1997) ; DEC2 (also known as BHLHB3/SHARP1) was identified from a human expression sequence tag database as a member of DEC subfamily (Fujimoto et al., 2001) .
In the present study, we focused on the mechanisms of downregulation of MLH1, and demonstrated for the first time that the hypoxia-inducible transcription repressors DEC1 and 2 participated in the transcriptional regulation through their bindings to E-box-like motif(s) in MLH1 promoter region. These findings may contribute to a better understanding of the biological functions of tumor hypoxia, based on the novel proposal that hypoxia-inducible DEC can impair MMR function through repression of MLH1 expression, and may subsequently cause genomic instability in cancer cells.
Results

MLH1 expression at both protein and mRNA levels under hypoxic conditions
We first examined whether hypoxia decreased MLH1 expression in cancer cells. HepG2 cells were collected after incubation under normoxic or hypoxic conditions for various periods. Immunoblotting using whole cell extracts revealed that hypoxia decreased MLH1 protein up to 48 h in an exposure time-dependent manner, unlike the stable expression levels of b-actin (Figure 1a) . The hypoxic induction of HIF-1a was confirmed at welldetected protein levels as well as that of DEC1, a known hypoxia-inducible transcriptional repressor, whereas aryl hydrocarbon receptor nuclear translocator (Arnt), also known as HIF-1b, and b-actin constitutively expressed ( Figure 1a) . Next, MLH1 mRNA levels were evaluated along with hypoxia-inducible genes, DEC1 and 2. Real-time RT-PCR analyses demonstrated that MLH1 mRNA level alone decreased from 6 to 48 h with hypoxic treatment (Figure 1b) . In contrast to MLH1, expressions of DEC1 and 2 increased under hypoxic conditions, despite of the relatively short duration of DEC2 upregulation (Figure 1b) . We further examined mRNA expression of these genes in the other cell lines and found the similar expression patterns (Figure 1c ). Figure 2b ). Interestingly, this promoter activity was repressed by co-transfection with DEC1 or 2 expression plasmid vector in a dose-dependent manner, and the repression of MLH1 promoter activity was notable when DEC2 was co-transfected ( Figure 2c ). As histone deacetylase (HDAC)-dependent mechanisms had been previously suggested (Sun and Taneja, 2000) , trichostatin A (TSA) treatments remarkably canceled the repression of MLH1 promoter activity by DEC in a treatment dose-dependent manner without any detectable cytotoxicity (Figure 2d ). Moreover, mutant type of DEC1 which had DNA-binding domain but lacked most of functional domains (Li et al., 2003; Sato et al., 2004) failed to repress MLH1 promoter activities, even enhanced them, suggesting that just a competitive occupancy on the promoter was not sufficient to explain the repression (Figure 2e ).
Response element to DEC on MLH1 promoter region
To identify a response element to DEC in the MLH1 promoter region, we constructed a series of deletion mutants of MLH1 promoter reporter ( Figure 3a ). The luciferase reporter assays for co-transfection with pcDNA (vector only) revealed that MLH1 promoter had several putative positive (from À556 to À274)-and negative (from À893 to À557)-regulatory regions. We also found that promoter activity of pGLMLH1Pro0.27 was almost identical to that of pGL-MLH1Pro1.65, indicating that the region from À273 to À4 probably contains critical regulatory regions. Furthermore, co-transfection with DEC-expressing pcDNAs showed that all of the reporter activities were significantly repressed by DEC, suggesting that the region from À273 to À4 is the most likely site containing the DEC-response element ( Figure 3a) .
We therefore constructed four mutant reporters in which several nucleotides were substituted in the putative E-box motifs ( Figure 3b ): Three mutants (MT1-3) showed stronger activity than that of the wild-type promoter reporter (Figure 3c ). Co-transfection experiments with DEC indicated that MT1 and MT2 showed resistance to the repression caused by hMLH1 transcriptional regulation by DEC H Nakamura et al DEC, whereas MT3 and MT4 were significantly repressed, as strongly as the wild type was (Figure 3c ). These results suggested that DEC might repress MLH1 expression through their bindings to the indicated region containing putative E-box motifs.
Direct binding of DEC to the response element containing E-box motif on MLH1 promoter To demonstrate that DEC directly binds to the response elements, we performed an electrophoretic gel mobility shift assay (EMSA) with 32 P-labeled probes containing Figure 1 Hypoxia decreased MLH1 expression and increased hypoxia-inducible factor-1a (HIF-1a), differentiated embryo chondrocyte (DEC) 1 and 2 expression in cancer cell lines. Protein levels of MLH1, HIF-1a, Arnt, DEC1 and b-actin (a), and mRNA levels of MLH1, DEC1 and DEC2 expressed in HepG2 (b) and HeLa, MCF-7 and HSC-2 (c) cells after indicated periods of hypoxic treatment analysed by immunoblotting or real-time RT-PCR method. Relative mRNA levels were calculated as the ratio to that of ACTB, and each bar represents the mean þ s.d. for at least three independent experiments. *Po0.05 and X0.01, **Po0.01. hMLH1 transcriptional regulation by DEC H Nakamura et al DEC-response elements in the MLH1 promoter from À69 to À47. DEC1 and 2 were synthesized using in vitro transcription/translation system, and protein amounts were equally adjusted by calculation of incorporated 35 S-labeled methionines. A 32 P-labeled probe was incubated with synthesized proteins and subjected to electrophoresis. EMSA showed that both DEC1 and 2 specifically bound to these elements (Figure 4a ), DEC1 or 2 probe-specific DNA-binding complexes had shifted and the complexes formed were competed out by pre-incubation with the nonlabeled probes or specific antibodies for DEC1 or 2. The observed intensities of shifted bands indicated that the binding activity of DEC2 to this probe was much stronger than that of DEC1.
Chromatin immunoprecipitation (ChIP) assay was then performed after incubation of HepG2 cells in normoxia or hypoxia for 24 h to examine the binding of endogenous DEC to response elements in MLH1 promoter. Real-time PCR clearly demonstrated that immunoprecipitation of the chromatin fragment containing the DEC-response element in MLH1 promoter 0 region (nt À1653 to À4) of MLH1 was subcloned into pGL3 Basic plasmid vector. (b) The MLH1 promoter reporter was transiently transfected into HepG2 cells, and promoter activities were evaluated under normoxic or hypoxic conditions. (c) Various amounts of DEC1 (hatched bar) or DEC2 (closed bar) expression vectors were co-transfected with MLH1 promoter luciferase reporter. Effects of trichostatin A (TSA) treatment (d) or DEC1 mutant (e, striped bar) on MLH1 promoter were evaluated by co-transfection assay. Relative luciferase activities were calculated as the ratio to activity of pRL-SV40. Each bar represents the mean þ s.d. for at least three independent experiments. *Po0.05 and X0.01, **Po0.01. hMLH1 transcriptional regulation by DEC H Nakamura et al was increased in the hypoxic samples pre-incubated with anti-DEC1 antibody, indicating that DEC1 specifically bound to the elements (Figure 4b ).
Expression of DEC and endogenous MLH1 protein
To confirm the function of DEC on MLH1 at the cellular level, we investigated endogenous MLH1 protein in cells overexpressing DEC. Immunoblotting analysis using whole cell extract prepared from HepG2 cells transiently transfected with DEC1 or 2 demonstrated that MLH1 protein decreased and inversely associated with the expression levels of DEC (Figure 5a ). To confirm the suggested function of DEC on MLH1 at each cellular level, we then performed immunostaining in HepG2 transiently transfected with DEC2. Double staining with anti-MLH1 and -DEC2 showed that MLH1 and DEC2 were compensatively expressed in each cell: MLH1 expression was significantly decreased in the DEC2 overexpressed cells, while high expression levels of MLH1 were maintained in cells without DEC2 expression (Figure 5b ). Next, we performed knockdown assay for HIF1A, DEC1 or DEC2, to estimate how HIF-1-DEC pathway contribute to the MLH1 expressions. As a result, transient transfection of specific siRNA for HIF1A in HSC-2 represented more than 80% reduction of HIF1A expression compared to that of nonspecific (Figure 5c ). Interestingly, DEC1 knockdown represented a little increased expression of MLH1 under both normoxic and hypoxic conditions. Since DEC1 represses DEC2 expression (Li et al., 2003) , DEC1 knockdown resulted in increased DEC2 expression and persistence of the hypoxic repression of MLH1 (H/N ratios of siDEC1 ¼ 0.69). On the other hand, DEC2 knockdown strikingly increased expression of MLH1 under hypoxic condition, indicating complete attenuation of hypoxic repression of MLH1 (H/N ratios of siDEC2 ¼ 1.01).
Discussion
Hypoxic reaction has been clearly shown to involve alterations in gene transcription (Harris, 2002; Denko et al., 2003; Semenza, 2003; Poellinger and Johnson, 2004) , and HIF-1 is well known as the pivotal factor that regulates cellular responses to hypoxia via transactivation of a variety of genes. We previously demonstrated that DEC1 and 2 were transcriptionally activated by HIF-1, suggesting their crucial roles in HIF-1-mediated cellular hypoxic reaction (Miyazaki et al., 2002) . The mechanisms of the activation of HIF-1 and the subsequent transactivation of various genes have also been intensively studied, which has promoted a better understanding of the genetic and molecular basis underlying intricate hypoxic reactions of cells (Harris, 2002; Denko et al., 2003; Semenza, 2003; Poellinger and Johnson, 2004) . However, little is known about the precise mechanisms and the factors causing transcriptional repression under hypoxia, despite their critical roles in cellular hypoxic reaction. In fact, decreased expression of DNA repair genes under hypoxia and a possible association with genomic instability were recently shown (Mihaylova et al., 2003; Bindra et al., 2004 Bindra et al., , 2005 Koshiji et al., 2005; Glazer, 2006, 2007) . The analysis of molecular mechanisms is of key importance in understanding cellular hypoxic reaction and its role in tumor biology, so we attempted to clarify the molecular mechanisms: we found that DEC1 and 2 strongly repress the promoter activity of MLH1, possibly via an HDAC-dependent mechanism but not by just a competitive occupancy on the promoter. We further identified a possible DEC-response element on the MLH1 promoter region, and confirmed the direct binding of DEC to that element. Forced expressions of both DEC1 and 2 efficiently repressed MLH1 promoter and expression, and knockdown of DEC2 by siRNA significantly attenuated hypoxic repression of the MLH1 expression. On the other hand, while knockdown of HIF1A also caused disappearance of hypoxic repression of MLH1, DEC1 knockdown failed to attenuate the MLH1 repression under hypoxic conditions, since decreased expression of DEC1 resulted in increased DEC2 expression as previously reported (Li et al., 2003) . Taken together, these results suggested that HIF-1-DEC pathway was one of the important mechanisms. Very recently, several mechanisms were suggested to participate in regulation of DNA repair genes, including E2F4/p130, HIF-1a/SP-1 and Myc/Max system. Bindra and Glazer (2007) demonstrated a dynamic shift in occupancy from activating c-Myc/Max to repressive Mid/Max and Mnt/Max complexes at the proximal promoters of MLH1 and MSH2 by using series of ChIP assays, but did not determine repressive activities of those complexes on the promoters. Although it is well known that both Myc/Max and DEC bind to E-box motif to regulate gene transcription, our experiments using mutant type of DEC1 that had DNA-binding domain but lacked most of functional domains failed to repress MLH1 promoter activities, even enhanced them, Figure 4 DEC directly bound to the DEC-response elements containing E-box motif on MLH1 promoter. (a) The electrophoretic gel mobility shift assay (EMSA) was performed as described in the 'Materials and methods'. Specificities of their bindings (asterisk (*) for DEC1 complex) were confirmed by preincubation with nonlabeled probes or specific antibodies for DEC1 or 2. NS, nonspecific band. (b) The chromatin immunoprecipitation (ChIP) assay was performed as described in the 'Materials and methods' using anti-DEC1, anti-DEC2 or anti-immunoglobulin G (IgG). Relative amounts of precipitated DNA fragments were evaluated by real-time PCR, and calculated using HepG2 genomic DNA as a standard. Each bar represents the mean þ s.d. for at least three independent experiments. *Po0.05 and X0.01. hMLH1 transcriptional regulation by DEC H Nakamura et al suggesting that just a competitive occupancy on the promoter was not sufficient to explain the repression, but HDAC-dependent repressive activities of DEC transcription factors were important. Since the loss of functions of MLH1 is thought to be a significant cause of the complete inactivation of MMR (Hoeijmakers, 2001; Peltoma¨ki, 2001 )-which may lead to carcinogenesis, tumor progression and emergence of resistance to anticancer therapies-these new findings, we believe, could contribute to a better understanding of the functional roles of hypoxia in malignant phenotypes of various tumors. Our data also suggested that DEC2 might repress MLH1 stronger than DEC1 does, which would be an important evidence of diversification of DEC functions. It has been suggested that DEC participates also in adipogenesis, circadian rhythm, immune system or carcinogenesis through transcriptional repressions of several genes via E-box or other motifs in their promoter regions (Honma et 
hMLH1 transcriptional regulation by DEC
H Nakamura et al Ivanova et al., 2007) . Their differential effects on MLH1 could be explained in part by varying specificity to the element sequence identified as the binding site, which contains a sequence motif of AACGTG with one nucleotide difference from canonical E-box motif (CACGTG). In this study, we found that mRNA expression of DEC1 increased for more than 72 h under hypoxia, while that of DEC2 only temporarily increased. Even so, DEC2 was shown to have much stronger affinity to the MLH1 promoter. These findings led us to hypothesize that DEC2 could be the initiator of the event, whereas DEC1 might act on the maintenance of the downregulated level of MLH1 expression. This hypothesis may be supported in a part by one report showing that DEC1 transcriptionally repressed DEC2 expression in an autofeedback system, suggesting their hierarchical functions (Li et al., 2003) . In the present study, we did not detect an endogenous DEC2 protein induction as well as other investigators, and did not observe DEC2 binding to MLH1 promoter in vivo using ChIP assay. On the other hand, knockdown experiments clearly showed a significant role of DEC2 in regulation of the MLH1. Taken together, it might be tough to detect endogenous DEC2 protein in both experiments due to an antibody activity, but DEC2 protein actually functions on MLH1 regulations. The diverse roles of DEC1 and 2 are now being intensively investigated in our laboratory.
In conclusion, we demonstrated here that the hypoxia-inducible transcription repressors DEC1 and 2 participate in transcriptional regulation of the MLH1 via their bindings to an E-box-like motif in the MLH1 promoter region. Hypoxia-induced DEC1 and 2, we think, probably play very important roles in the transcriptional downregulation of genes under hypoxia, and the HIF-1-DEC pathway as well as other pathways may impair MMR function through the repression of MLH1 expression, subsequently causing genomic instability in cancer cells (Figure 5d ).
Materials and methods
Chemicals
All chemicals were of analytical grade and were purchased from Wako Pure Chemicals (Osaka, Japan) or Sigma (St Louis, MO, USA).
Cell lines and RNA preparation
Human cancer cell lines used were as follows: a hepatoma line, HepG2 and an oral squamous cell carcinoma line, HSC-2 (the Japanese Cancer Research Resource Bank); a cervical adenocarcinoma line, HeLa and a breast adenocarcinoma line, MCF-7 (American Type Culture Collection). For gene expression analyses, cells (2-4 Â 10 5 per 10 cm diameter dish) were cultured under normoxic (21% O 2 ) or hypoxic (1% O 2 ) conditions for various incubation times (6, 12, 24, 48 or 72 h) in a hypoxic chamber (Hirosay Corp., Hiroshima, Japan). For knockdown analyses, HIF1A, DEC1, DEC2 or NS siRNA (Qiagen Inc., Valencia, CA, USA) was transfected with TransIT-siQUEST Transfection Reagent (Mirus Corporation, Madison, WI, USA) in HSC-2 (1 Â 10 6 per 10 cm diameter dish) for 12 h, and then the cells were incubated under normoxic or hypoxic conditions for 24 h. Cells were then harvested and stored at À80 1C until use. Total RNA was prepared from frozen cell pellets by using Qiagen RNeasy mini kit (Qiagen) according to the manufacturer's instruction.
Reverse transcription-polymerase chain reaction
In total 2 mg of total RNA extracted from each cell line were reverse-transcribed using High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). Two-hundredth aliquot of the cDNA was subjected to real-time RT-PCR using TaqMan Gene Expression Assays (Applied Biosystems) for HIF1A, BHLHB2 (DEC1), BHLHB3 (DEC2) and MLH1, and Pre-Developed TaqMan Assay Reagents (Applied Biosystems) for ACTB as an internal control. More than three independent measurements were averaged and relative gene expression levels were calculated as a ratio to ACTB expression of each cell line.
Immunoblot analysis
To analyse protein expression, whole cell extracts were prepared from cultured cells with or without hypoxic treatment as previously described (Tanimoto et al., 2000) . In total 25 mg of protein was blotted onto nitrocellulose filters following SDS-polyacrylamide gel electrophoresis. Anti-FLAG (Sigma), anti-MLH1, anti-HIF-1a, anti-Arnt (BD Pharmingen, San Diego, CA, USA) or anti-b-actin (Sigma) were used as primary antibodies, diluted 1:5000, 1:2000, 1:1000, 1:2000 or 1:5000, respectively. A 1:2000 dilution of anti-mouse immunoglobulin G (IgG) horseradish peroxidase conjugate (GE Healthcare, Tokyo, Japan) was used as a secondary antibody. Immunocomplexes were visualized using the enhanced chemiluminescence reagent ECL Plus (GE Healthcare).
Plasmid constructions
The 1.65-kb DNA fragment (nucleotide positions from À1653 to À4 when transcriptional start site is designated as at þ 1) including the 5 0 region of MLH1 gene was amplified by PCR from a HepG2 genomic DNA and subcloned into Nhe I and Xho I sites of a luciferase reporter plasmid pGL3-Basic or pGL4.10 (Promega), and the construct was designated as pGL-MLH1 Pro1.65. A series of 5 0 deletion mutant of pGL-MLH1 Pro was constructed by PCR method using internal specific primer sets with pGL-MLH1 Pro1.65 as a template. Base-exchanged mutants of putative E-box sites in pGL-MLH1 Pro0.27 were generated by PCR-based sitedirected mutagenesis as previously reported (Tanimoto et al., 2003) . Details of expression plasmid vectors of DEC1 (pcDNA-DEC1, p3xFLAG-CMV-DEC1 or pcDNA-DEC1 1-139) and DEC2 (pcDNA-DEC2) were previously described Sato et al., 2004) . pcDNA-FLAG-DEC2 was constructed by swapping DEC2 cDNA fragment of pcDNA-DEC2 with the pcDNA-FLAG (kindly provided by Dr Igarashi).
Luciferase reporter assay
Transient transfection was performed as follows: pGL-MLH1 Pro (0.3 mg per 15-mm well) with pcDNA-FLAG, p3xFLAG-CMV-DEC1 or pcDNA-FLAG-DEC2 (0.001-0.1 mg per 15-mm well) were mixed with 0.8 ml of Trans-IT LT1 Transfection Reagent (Mirus). Renilla-luciferase vector (pRL-SV40, 1.0 ng per 15-mm well) (Promega) was used as a transfection efficacy control. Cells were incubated under normoxic or hypoxic conditions for 36-48 h after transfection prior to analysis of luciferase reporter activity. Using the HDAC inhibitor, TSA, treatments were started (final concentrations 10 or 100 ng/ml) 24 h before harvesting cells. Luciferase luminescence was measured as previously described (Tanimoto et al., 2003) .
Electrophoretic gel mobility shift assay Double-stranded oligoprobes containing consensus DECbinding sequences in the MLH1 promoter from À69 to À47 were synthesized as follows: sense, 5 0 -AAGAAC GTGAGCACGAGGCACTGGG-3 0 and antisense, 5 0 -CA GTGCCTCGTGCTCACGTTCTTGG-3 0 and labeled with [a-32 P]-deoxycytidine triphosphate. Adjusted equal amounts of in vitro translated DEC1 or 2 were incubated with 200 pmol of labeled probe in 20 ml of reaction mixture for 30 min at room temperature. A 100-fold excess amount of unlabeled probes for competition or 2.5 ml of anti-DEC1 or 2 polyclonal antibody for supershift was pre-incubated for 30 min at room temperature before the addition of hot-labeled probes. The reaction mixtures were then loaded onto 5% polyacrylamide gels and were run for 4 h at 4 1C. Resulting gels were dried and visualized using BAS2000.
Chromatin immunoprecipitation assay
The ChIP assay was performed using EZ ChIP Chromatin Immunoprecipitation Kit (Upstate USA Inc., Charlottesville, VA, USA) according to the manufacturer's instruction. Anti-DEC1 or 2 rabbit polyclonal antibody was used for a specific precipitation, and anti-IgG mouse monoclonal antibody was used as a negative control for an immunoprecipitation. The PCR primer set was synthesized to encompass the candidate DEC-binding sites in MLH1 promoter as follows: forward, 5 0 -ATCAATAGCTGCCGCT GAA-3 0 and reverse, 5 0 -CTCGTGCTCACGTTCTTCCT-3 0 , and the probe (#42) was selected from Universal Probe Library (UPL, Roche Diagnostics, Tokyo, Japan). Real-time PCR was performed using the 1/30 volume of precipitates. Three independent measurements were averaged and relative amounts were calculated as a ratio to amplicons using HepG2 genomic DNA.
Immunostaining
HepG2 cells grown on cover slips were transiently transfected with DEC2 expression plasmid, pcDNA-DEC2. After incubation for 24 h, immunostaining was performed with anti-DEC2 (1:100) or anti-MLH1 (1:100) as primary antibodies, fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit Ig's (1:100) (BioSource, Camarillo, CA, USA) or Rhodamineconjugated sheep anti-mouse Ig's (1:100) (Chemicon, Temecula, CA, USA) as secondary antibody. Nuclei were stained with 4-6-diamidino-2-phenylindole (DAPI). Subcellular distribution of fluorescence was examined using a Zeiss Axiovert 135 microscope with an FITC-filter set, epifluorescence with illumination from a Gixenon burner (Carl Zeiss Jena GmbH, Jena, Germany).
Statistical analysis
All of the statistical tests were performed using StatView version 5.0 software (SAS Institute Inc., Cary, NC, USA), and Student's t-test was used to determine the P-value.
